The results indicated that the expression of PGK1 was distinctly upregulated in most types of cancers, including bladder urothelial carcinoma (BLCA), head and neck squamous cell carcinoma (HNSCC), and lung adenocarcinoma (LUAD) (Figure 8A). Here, PGK1 is linked to bladder transitional cell carcinoma.